Wednesday, November 22, 2017 12:40:52 PM
Nov 10, 2017
OTC Disclosure & News Service
-
Cresco, PA., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Net Savings Link, Inc. (OTC: NSAV), announced today that the Company will commence a private pre-ICO sale for its MJCoin Digital Currency on December 1, 2017. MJCoin will provide payment solutions to the legal cannabis and hemp industries and will be backed by the strength of the legal cannabis and hemp markets. The Company’s ultra-secure digital cryptocurrency will be minted on Ethereum Blockchain. Further details, including the private pre-sale bonus, will be released within the next two weeks.
NSAV previously announced plans to launch its cryptocurrency exchange immediately following the proposed January 2018 ICO, in order to enable trading of MJCoin to commence expeditiously. The Company believes that having its own digital currency will allow it to become a key player in the $100 billion global legal cannabis and hemp
industries.
Earlier in the week, NSAV announced that the Company’s 4.0 billion or 40% reduction of its authorized shares has been approved by the Company’s transfer agent, Pacific Stock Transfer and is now official. The management of NSAV firmly believes that this major share reduction is in the best interest of all of its shareholders and part of the Company’s commitment to enhance shareholder value.
James Tilton, president of NSAV stated, “I am truly pleased that we are offering a private pre-sale for our MJCoin Digital Currency. I can’t tell you how many requests we’ve had from our shareholders enquiring about a pre-sale. I can assure all of our loyal shareholders that they will benefit from our pre-ICO MJCoin sale.”
NSAV's vision is the establishment of a fully integrated technology company that provides turnkey technological solutions to the legal medical cannabis and hemp industries, as well as other areas of the medical industry. Over time, the Company plans to provide a wide range of services such as software solutions, e-commerce, advisory services, financial services, patents and trademarks and information technology.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM